Beranda › Leukemia Mieloid Kronis
Uji klinis Leukemia Mieloid Kronis yang merekrut di AS
48 studi untuk Leukemia Mieloid Kronis merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX18 studi
- Seattle, WA11 studi
- New York City, NY11 studi
- Detroit, MI6 studi
- Birmingham, AL6 studi
- Philadelphia, PA6 studi
- Chicago, IL6 studi
- Baldwin Park, CA6 studi
- Portland, OR6 studi
- Nashville, TN5 studi
- Columbus, OH5 studi
- Milwaukee, WI5 studi
- Baltimore, MD5 studi
- Atlanta, GA5 studi
- Boston, MA5 studi
- Durham, NC5 studi
- Rochester, NY4 studi
- Mountain View, CA4 studi
- Cincinnati, OH4 studi
- Kansas City, MO4 studi
- Augusta, GA4 studi
- Washington, DC4 studi
- St. Louis, MO4 studi
- Sacramento, CA3 studi
- Edison, NJ3 studi
- Salt Lake City, UT3 studi
- Cleveland, OH3 studi
- Orange, CA3 studi
- Miami, FL3 studi
- Bridgeport, CT3 studi
- Buffalo, NY3 studi
- Ann Arbor, MI3 studi
- Aurora, CO3 studi
- St. Petersburg, FL3 studi
- Greenville, NC3 studi
- Minneapolis, MN3 studi
Berdasarkan negara bagian
- Alabama6 studi
- Arizona4 studi
- California10 studi
- Colorado4 studi
- Distrik Columbia3 studi
- Florida7 studi
- Georgia7 studi
- Illinois6 studi
- Indiana3 studi
- Kansas5 studi
- Kentucky3 studi
- Maryland6 studi
- Massachusetts5 studi
- Michigan7 studi
- Minnesota4 studi
- Missouri4 studi
- Nebraska3 studi
- New Jersey4 studi
- New York15 studi
- North Carolina8 studi
- Ohio9 studi
- Oregon6 studi
- Pennsylvania7 studi
- Tennessee5 studi
- Texas18 studi
- Utah3 studi
- Virginia4 studi
- Washington11 studi
- Wisconsin5 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06904066Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Menerima pesertaStudi observasional
Usia 0 hingga 38 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06131801Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06817720Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
Menerima pesertaFase 1/2
Usia 1 hingga 17 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04925479Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07269470Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06236724Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06398457Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Menerima pesertaFase 1
Usia 1 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT03630991Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT01746836Study of Olverembatinib (HQP1351) in Patients With CML-CP
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06423911Cord Blood Transplant in Adults With Blood Cancers
Menerima pesertaFase 2
Usia 21 hingga 65 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05884333Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Menerima pesertaFase 2
Usia 1 hingga 18 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07354074Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT06523556Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Menerima pesertaFase 1
1 Day – 21 Years · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT05857969Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04838041TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Menerima pesertaFase 1
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07302776Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Menerima pesertaFase 2
6 Months – 65 Years · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT06013423A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545Allo HSCT Using RIC and PTCy for Hematological Diseases
Menerima pesertaFase 2
Hingga usia 75 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT05805605Asciminib Roll-over Study
Menerima pesertaFase 4
Usia 7 hingga 100 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT04877522Registry of Older Patients With Cancer
Menerima pesertaStudi observasional
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT01137825Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Menerima pesertaFase 2
Hingga usia 60 · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT03314974Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT05549661Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT07638007Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.